International Panel Physicians Association selects QFT-Plus for its proven value in diagnosing latent TB infection Germantown, Maryland, and Hilden, Germany – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that its QuantiFERON-TB® Gold Plus (QFT-Plus), the gold standard in accurate, cost-effective testing for latent tuberculosis (TB) infection, has been endorsed for immigration medical screening by the International Panel […]
Ludwigshafen, Germany, and Chengdu, China – BASFand HitGen Ltd. have entered into a research collaboration to identify novel, small molecule leads for targets of agrochemical interest to BASF. In this collaboration, HitGen will apply its advanced technology platform, based on DNA-encoded library design, synthesis and screening, to discover novel leads for BASF. “We are delighted […]
New website increases accessibility to leading-edge product range and latest information CORALVILLE, IA – As advocates for the genomics age, Integrated DNA Technologies (IDT), has launched a new version of its website designed to enhance support to researchers across the globe. The updated website features easy-to-find product information arranged by application and fast navigation – saving […]
MENLO PARK, Calif — Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leader in long-read, high-resolution sequencing, today announced that the U.S. Patent and Trademark Office (“USPTO”) has issued U.S. Patent No. 9,910,956 (the “956 Patent”), entitled “Sequencing using concatemers of copies of sense and antisense strands.” The 956 Patent was issued on March 6, 2018, and covers novel […]
Brings unmatched bench-to-bedside expertise to catalyze the adoption of precision medicine SAN DIEGO—Illumina, Inc. (NASDAQ:ILMN) announced today the appointment of Dr. Phil Febbo, a leading physician scientist, as Chief Medical Officer (CMO), starting March 26, 2018. In his new role, Dr. Febbo will be responsible for developing and executing on the Company’s medical strategy to drive genomic testing into […]
Hilden, Germany, and San Carlos, CA – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA), a world leader in providing Sample to Insight molecular solutions, and Natera, Inc. (NASDAQ: NTRA), a leading developer of next-generation sequencing (NGS) assays that include non-invasive prenatal genetic testing and the analysis of circulating tumor DNA, today announced a partnership to […]
WASHINGTON — Danaher Corporation (NYSE: DHR) (the “Company”) and Integrated DNA Technologies (“IDT”) announced today that Danaher has entered into a definitive agreement to acquire IDT, a privately-held provider of high-value consumables for genomics applications in molecular biology, qPCR, next generation sequencing, synthetic biology, gene editing and molecular diagnostics. IDT’s primary business is the manufacturing of […]
PierianDx, the leading genomics technology company that enables precision medicine, announced today a full range of expanded services to support adoption of the company’s enterprise software platform, the Clinical Genomics WorkSpace (CGW). “Since PierianDx was first founded in 2014, our mission has always been to enable precision medicine for our customers,” said PierianDx founder and CEO […]
Highlights: Acquisition advances Agilent’s growth strategy. Highly attractive business with robust growth track record and prospects. Combination strengthens customer value proposition with complementary technologies and solutions. Opportunity to accelerate expansion into adjacent businesses. SANTA CLARA, Calif. Agilent Technologies, Inc. (NYSE: A) today announced that it has signed a definitive agreement to acquire privately-held Advanced Analytical Technologies, Inc. (AATI), a provider of capillary electrophoresis-based (CE) […]
El Segundo, CA – BioDiscovery, Inc., a leader in innovative genomic data analysis software solutions announced today that BioDiscovery and Thermo Fisher Scientific have formed a partnership creating an assay plus analysis cancer research package with Nexus Express for OncoScan™ software for Thermo Fisher’s Cancer Research portfolio. BioDiscovery initially began the partnership three years ago with Affymetrix, […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
